Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression
Clinical trial NCT06839144 · RECRUITING
Trial details
- NCT number
- NCT06839144
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-12
- Primary completion
- 2026-08-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.